Wilm's Tumor

7 registered clinical trials studyying Wilm's Tumor.

Status	Trial	Sponsor	Phase
Completed	Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides NCT01598454	Laboratorio Elea Phoenix S.A.	Phase 1
Withdrawn	RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia NCT01236586	National Cancer Institute (NCI)	Phase 1
Completed	Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients NCT01169584	Jennerex Biotherapeutics	Phase 1
Completed	Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions NCT00758108	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	—
Completed	Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer NCT01445379	National Cancer Institute (NCI)	Phase 1
Completed	A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation NCT00405327	University of Michigan Rogel Cancer Center	Phase 2
Withdrawn	National Wilm's Tumor Study Late Effects NCT00228696	Emory University	N/A